U.S Physical Therapy Net Income 2010-2023 | USPH

U.S Physical Therapy net income from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
U.S Physical Therapy Annual Net Income
(Millions of US $)
2023 $28
2022 $32
2021 $41
2020 $35
2019 $40
2018 $35
2017 $22
2016 $21
2015 $21
2014 $19
2013 $13
2012 $18
2011 $21
2010 $16
2009 $12
U.S Physical Therapy Quarterly Net Income
(Millions of US $)
2023-12-31 $1
2023-09-30 $9
2023-06-30 $11
2023-03-31 $7
2022-12-31 $3
2022-09-30 $10
2022-06-30 $11
2022-03-31 $9
2021-12-31 $10
2021-09-30 $10
2021-06-30 $12
2021-03-31 $8
2020-12-31 $13
2020-09-30 $11
2020-06-30 $10
2020-03-31 $1
2019-12-31 $8
2019-09-30 $9
2019-06-30 $15
2019-03-31 $8
2018-12-31 $10
2018-09-30 $8
2018-06-30 $9
2018-03-31 $7
2017-12-31 $7
2017-09-30 $5
2017-06-30 $5
2017-03-31 $5
2016-12-31 $5
2016-09-30 $5
2016-06-30 $6
2016-03-31 $4
2015-12-31 $5
2015-09-30 $6
2015-06-30 $6
2015-03-31 $4
2014-12-31 $3
2014-09-30 $5
2014-06-30 $6
2014-03-31 $4
2013-12-31 $4
2013-09-30 $0
2013-06-30 $5
2013-03-31 $4
2012-12-31 $4
2012-09-30 $5
2012-06-30 $5
2012-03-31 $4
2011-12-31 $8
2011-09-30 $4
2011-06-30 $5
2011-03-31 $4
2010-12-31 $4
2010-09-30 $4
2010-06-30 $4
2010-03-31 $3
2009-12-31 $2
2009-09-30 $3
2009-06-30 $4
2009-03-31 $3
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.585B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.269B 10.45
Quest Diagnostics (DGX) United States $15.262B 15.77
DaVita (DVA) United States $11.791B 14.65
Chemed (CHE) United States $8.503B 26.36
Encompass Health (EHC) United States $8.333B 21.45
Elanco Animal Health (ELAN) United States $6.685B 15.20
Option Care Health (OPCH) United States $5.181B 19.61
RadNet (RDNT) United States $3.783B 102.40
Amedisys (AMED) United States $3.009B 21.31
LifeStance Health (LFST) United States $2.546B 0.00
Astrana Health (ASTH) United States $2.099B 26.20
Addus HomeCare (ADUS) United States $1.608B 24.43
Pennant (PNTG) United States $0.642B 37.54
Aveanna Healthcare Holdings (AVAH) United States $0.448B 0.00
Atai Life Sciences (ATAI) Germany $0.343B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00